Regulatory PathRegulatory requirements compared

Active substance

Menotrophin

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
MENOPUR 75 IU POWDER FOR SOLUTION FOR INJECTION75 IUPowder and solvent for solution for injection · Intramuscular use10 VialSAR 608.40NCE · PrescriptionFerring GmbHValid
MENOPUR 75 IU powder for solution for injection75 IUPowder and solvent for solution for injection · intramuscular, subcutaneous5 VialSAR 313.45NCE · PrescriptionFERRINGValid
MENOPUR Multidose600 IUPowder and solvent for solution for injection · Subcutaneous use1 VialSAR 501.50NCE · PrescriptionFERRINGValid
MENOPUR Multidose1200 IUPowder and solvent for solution for injection · Subcutaneous use1 VialSAR 1002.95NCE · PrescriptionFERRINGValid
MERIONAL HG150 IUPowder and solvent for solution for injection · intramuscular, subcutaneous1 VialSAR 138.00Biological · PrescriptionIBSA INSTITUTE BIOCHIMIQUE S.AValid
Merional HG75 IUPowder and solvent for solution for injection · intramuscular, subcutaneous1 VialSAR 69.00Biological · PrescriptionIBSA INSTITUTE BIOCHIMIQUE S.AValid

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.